Harvey Capital Management Inc Bridge Bio Pharma, Inc. Transaction History
Harvey Capital Management Inc
- $422 Million
- Q4 2024
A detailed history of Harvey Capital Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Harvey Capital Management Inc holds 12,900 shares of BBIO stock, worth $415,766. This represents 0.08% of its overall portfolio holdings.
Number of Shares
12,900Holding current value
$415,766% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$814 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$810 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$486 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$401 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$199 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.78B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...